IDE574 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12 results for “IDE574”

Trials

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

160 participants · First posted Apr 20, 2026

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

150 participants · First posted Mar 31, 2026

Drugs

IDD594

C₁₆H₁₂BrF₂NO₃S

News

IDEAYA Biosciences Submits IND for First-in-Class KAT6/7 Dual Inhibitor IDE574 Targeting Breast and Lung Cancers

IDEAYA Biosciences Completes Enrollment in Pivotal Uveal Melanoma Trial, Advances Novel ADC Program

IDEAYA Biosciences Licenses Biocytogen's B7H3/PTK7 Bispecific ADC for Solid Tumors

Page 1 of 2